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Abstract
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)
remains a poorly understood clinical entity. It is currently classiﬁed as a
premalignant condition by the World Health Organization (WHO). Symptoms are similar to those associated with obstructive lung disease, including
breathlessness and cough. The presentation is often initially ascribed to
other diseases such as asthma or chronic obstructive pulmonary disease.
Here, we present what we believe is the ﬁrst described case of DIPNECH
diagnosed by transbronchoscopic cryoprobe biopsy. The patient presented
with chronic cough, dyspnoea, pulmonary function tests consistent with
obstruction, and a computed tomography (CT) scan of chest with multiple
nodules. The patient went on to have transbronchoscopic cryoprobe biopsies of the lung, which conﬁrmed the diagnosis of DIPNECH.

doi: 10.1002/rcr2.275

Introduction
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is an uncommon pulmonary disease,
recognized by the World Health Organization (WHO) as a
precursor to carcinoid tumours. Pathology is precipitated
by pulmonary neuroendocrine cells (PNEC) and neuroepithelial bodies (NEB), leading to interstitial and peribronchiolar ﬁbrosis. More common in females, patients
characteristically present with chronic cough and dyspnoea,
often with evidence of obstruction on pulmonary function
testing (PFT). Progressive obstructive pulmonary deﬁcits
are a result of its association with obstructive bronchiolitis
[1]. High-resolution chest computed tomography (CT) can
be unremarkable but will frequently show mosaic attenuation with air trapping, pulmonary nodules, and ﬁbrosis.
The nodules may be so innumerable that they raise concern
for metastatic malignancy. Surgical lung biopsy is the gold
standard for the diagnosis of DIPNECH due to the large
amount of tissue required for the proper pathological

analysis [2]. Transbronchial biopsy (TBB) plays an important role in the diagnosis of various pulmonary diseases,
such as sarcoidosis and malignancies; however, it has been
less useful as a tool in the diagnosis of interstitial lung diseases or, in this case, DIPNECH. The primary reason for
this latter observation may be the relatively small size of the
biopsies obtained by routine TBB [3].
A novel approach to patients with suspected DIPNECH may be the use of transbronchoscopic cryoprobe
biopsy. The specimen sizes obtained are typically larger
than those obtained by TBB. This may increase the diagnostic yield of various parenchymal lung diseases and, in
effect, mitigate the need for open surgical lung biopsy or
video-assisted thoracic surgical biopsy [4]. The histopathological differential diagnosis includes reactive proliferation of PNEC in chronically damaged or inﬂamed lung;
however, the absence of damaged or inﬂamed lung
excludes this. Despite using the biopsy method, the distinct pathological ﬁndings described above would conﬁrm
DIPNECH.
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Case Report
A 41-year-old Hispanic female with no smoking history
presented after a 3-year history of predominantly dry cough
and an abnormal CT scan of the chest. She was living in
Arizona at the time of symptom onset and was diagnosed
with Chlamydia pneumoniae on sputum cultures. She completed a 3-month course of doxycycline due to persistence
of symptoms. Past medical history is signiﬁcant for gastroesophageal reﬂux disease, well controlled with oral pantoprazole, in addition to no recent hospitalization or sick
contacts. Physical examination reveals a 98 F temperature,
blood pressure 122/90 mmHg, pulse 70 bpm, respirations
of 15/min, peripheral capillary oxygen saturation (SpO2)
95% on room air at rest, and body mass index (BMI) of 32.
Head and neck examination of any palpable adenopathy is
absent. Cardiovascular examination is normal. Lungs reveal
mild late-end expiratory wheezes bilaterally. Abdomen is
large, without palpable organomegaly or tenderness. There
is no cyanosis, clubbing, or oedema. Medications such as
albuterol, montelukast, pantoprazole, tiotropium, calcium,
and cyanocobalamin are inhaled. Laboratory studies are
normal, including complete blood count (CBC) with differential, comprehensive metabolic panel, and serum total
immunoglobulin E (IgE). Her PFT shows evidence of severe
obstruction with no bronchodilator response, mild restriction, and reduced Diffusing capacity for carbon monoxide
(DLCO), which is normal when corrected for alveolar volume. Her chest X-ray is unremarkable. CT chest (Fig. 1)
shows air trapping with bilateral diffuse micronodularity.
The lingular bronchoalveolar lavage (BAL) is efﬂuent, with

62% lymphocytes, which is neither speciﬁc nor sensitive for
DIPNECH. Biopsies from the lateral, medial, and posterior
segments of the right lower lobe are obtained via transbronchoscopic cryoprobe. Histopathology (Fig. 2) in all
biopsy specimens shows normal alveolar parenchyma and
large amounts of bronchial wall mucosa. Within the bronchial submucosa is a focal 1.2-mm carcinoid tumourlet.
Well differentiated neuroendocrine cell hyperplasia with
scattered small nests and a focal linear array of PNEC are
present throughout the base of the bronchial mucosa,
which are consistent with DIPNECH. Few patients with
DIPNECH progress to respiratory failure. She remains clinically stable, which is consistent with the majority of
patients with DIPNECH.

Discussion
There has been an increased diagnostic and therapeutic
role for ﬂexible ﬁbre-optic bronchoscopy since its introduction by Ikeda in 1968. Transbronchial biopsy is often
considered in the evaluation of patients with abnormal CT
scans of the chest, the limitations of which include the
small size of the typical biopsy specimen and crush artefact. Diagnostic yield improves with increased quantity
and size of biopsies via larger forceps. These adjustments,
however, have not signiﬁcantly improved the ability to
diagnose a multitude of diffuse interstitial lung diseases [3].
Introduced in the late 1990s, transbronchoscopic cryoprobe has shown promise as a useful diagnostic tool for

Figure 1. Computed tomography of
the chest without evidence of bronchiectasis but showing multiple
micronodules (arrow heads) and a
mosaic appearance in keeping with
air trapping.
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Figure 2. (A) Large size of the transbronchial cryobiopsy (haematoxylin
and eosin (H&E), 12.5×). (B) Carcinoid
tumourlet is identiﬁed as nests of neuroendocrine cells forming a 1.2-mm
mass adjacent to the bronchiole (H&E,
100×). These nests were positive for
chromogranin. (C) Proliferation of neuroendocrine cells under the ciliated
respiratory epithelium (arrow) with
mucinous metaplasia (arrow head)
(H&E, 600×). (D) Positive staining for
chromogranin conﬁrms the neuroendocrine nature of the proliferation
(chromogranin immunohistochemistry, 400×).

many diffuse parenchymal lung diseases. The cryoprobe
system operates under the Joule-Thomson effect, where a
compressed gas (nitric oxide or carbon dioxide) under
high ﬂow rapidly expands upon exposure to atmospheric
pressure, yielding a temperature of −89 C for N2O and
−69 C for CO2. The probe comes in two diameters of
1.9 mm and 2.4 mm. Prior to performing the biopsy, the
probe’s location is conﬁrmed under ﬂuoroscopy. Despite
the size of probe, the tissue mass is larger and of superior
quality, with fewer crush artefacts and intact structural
integrity compared to the TBB specimen. A less-invasive
diagnostic procedure has the potential to reduce complications following open lung biopsy, including increased 90day mortality, cardiac arrhythmias, infections, prolonged
air leakage, and persistent thoracic pain [4].
At Tampa General and James A. Haley Veterans Hospitals, this procedure is performed under general anaesthesia
with endotracheal intubation. A BAL is performed prior to
biopsy, after which the biopsy site is irrigated with 4 mL
epinephrine. Once the site, at least 15 mm proximal from
the pleura, is conﬁrmed with ﬂuoroscopy, the target is frozen for 3–5 s. The cryoprobe is removed with the bronchoscope from the endotracheal tube, and the sample is
placed in formaldehyde solution. In the event of bleeding,
50 mL aliquots of cold saline followed by 1–2 mL topical
epinephrine (1:10,000) can be used for haemostasis. Fluoroscopy is used to assess for evidence of pneumothorax.

Data collected from over 300 cryobiopsies performed at
these hospitals had a 5.4% incidence of pneumothorax and
no signiﬁcant bleeding [5].
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